Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hiya. Today, we explore a gene therapy approach that’s drawing excitement but also skepticism, and see that Jennifer Doudna is moving into AI-designed gene editors that push beyond evolution. 

Plus, our trusty podcasters unpack the buzzy prediction market Kalshi’s move into biotech.

Continue to STAT+ to read the full story…